The Affordable Medicines Facility - マラリア:ゆっくりと殺す
Kenneth J Arrow1, Patricia M Danzon, Hellen Gelband
1Department of Economics, Stanford University, Stanford, CA, USA.
Lancet (London, England)
|November 6, 2012
まとめ
No abstract available in PubMed .
関連する概念動画
Pulmonary Tuberculosis V
460
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
460
Therapeutic Drug Monitoring: Affecting Factors
118
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
118


